New research tabs a natural byproduct of metabolism as a potent trigger of cancer spread. (STAT Plus)

More reads

• Otsuka approved to buy the assets of bankrupt smart-pill maker Proteus, overcoming pushback from Novartis. (STAT Plus)
• Biotech is priced for bad reactions. (Wall Street Journal)
• New research tabs a natural byproduct of metabolism as a potent trigger of cancer spread. (STAT Plus)
• Martin Shkreli fails to end FTC, New York lawsuit over Daraprim price hikes. (Reuters)